So What Happens if You Get Injured by a COVID-19 Vaccine?
Opinion | The experimental COVID-19 vaccines are being released first to a designated group of health care workers and residents of senior living facilities. As more of the vaccines becomes available, people at high-risk to the SARS-CoV-2 virus due to their medical conditions will be given an opportunity to get vaccines. Finally, the general public […]
Over 3,000 “Health Impact Events” After COVID-19 mRNA Vaccinations
Between Dec. 11 and 18, 2020, the U.S. Food and Drug Administration (FDA) granted Pfizer/BioNTech and Moderna pharmaceutical companies an Emergency Use Authorization (EUA)1 to distribute COVID-19 vaccines using messenger RNA (mRNA) technology that to date has not been licensed for use in humans.2 3 4 5 Although the Advisory Committee on Immunization Practices (ACIP) […]
Government Proposes Making It Harder to Get Vaccine Injury Compensation
In July 2020, the U.S. Department of Health and Human Services (HHS) published a notice of proposed rule making in the Federal Register1 that would remove shoulder injuries and vasovagal syncope from the Vaccine Injury Table used by the National Vaccine Injury Compensation Program (NVICP). The proposed rule making would also eliminate Item XVII, whereby […]
Another Shot at a Vaccine for Lyme Disease
The U.S. National Institutes of Health (NIH) has provided the University of Maryland with a $3.5 million dollar grant to develop a vaccine for Lyme disease.1 Principal investigators Utal Pal, PhD, professor at the Virginia-Maryland College of Veterinary Medicine at the University of Maryland College of Agriculture and Natural Resources and Matthias Schnell, PhD, director […]
CureVac’s COVID-19 Vaccine Produces Grade 3 Adverse Events
Biopharmaceutical company CureVac NV of Tübingen, Germany has released the interim results of its Phase 1 clinical trial on its experimental CVnCoV vaccine COVID-19. The vaccine, which was given to more than 250 healthy adults 18 to 60 years of age, is based on messenger ribonucleic acid (mRNA) technology.1 2 Unlike traditional vaccines, mRNA vaccines […]
Moderna’s COVID-19 Vaccine Provokes ‘COVID-Like Symptoms’ in Phase 3 Trial
Biotechnology firm Moderna, Inc. of Cambridge, Massachusetts began a Phase 3 human clinical trial to test the safety and efficacy of its experimental mRNA-1273 COVID-19 vaccine on July 27, 2020. The randomized, placebo-controlled trial involves giving two 100-microgram doses of the vaccine to 28,618 volunteer participants over 18 years of age, including some elderly people […]